Jubilant Ingrevia hits 14-quarter revenue high on 12% growth
The specialty chemicals firm posted a 17% jump in quarterly profit to ₹86 crore, as volume growth across all segments offset supply chain headwinds.
— 4 earlier stories on Jubilant Ingrevia Ltd. →What's new
- Q4 revenue rose 12% YoY to ₹1,179 crore, with 10% volume growth across all segments.
- Net profit climbed 17% to ₹86 crore, while EBITDA reached ₹172 crore.
- The board declared a final dividend of ₹2.50 per share, totaling ₹5 for FY26.
Why this matters
Jubilant Ingrevia is demonstrating that its volume-led growth strategy is working even when global logistics are under pressure. The ability to maintain 15% margins while scaling production at its new agro CDMO facility suggests the company is successfully executing its transition toward higher-value products.
What we're watching
- Management's commentary on the 'Pinnacle' strategy during the upcoming concall.
- Sustained margin performance as the new agro CDMO facility ramps up.
- Sequential growth targets for Q1FY27 in specialty chemicals and nutrition.
The full read
Jubilant Ingrevia closed FY26 with its strongest quarterly performance in 14 quarters. Consolidated revenue reached ₹1,179 crore, a 12% year-on-year increase, supported by a 10% rise in volumes across all business segments. Profitability followed suit, with EBITDA rising 11% to ₹172 crore and net profit growing 17% to ₹86 crore. Margins remained steady at 15%. The company successfully managed Middle East supply chain disruptions, ensuring no production loss, and has already begun shipping from its new agro CDMO facility. Shareholders will receive a final dividend of ₹2.50 per share, bringing the annual total to ₹5. Management is now looking ahead, projecting sequential revenue and EBITDA growth for Q1FY27, specifically targeting the specialty chemicals and nutrition divisions as the primary engines for the next phase of expansion.
Questions answered
- What drove the revenue growth in the final quarter?
- Revenue growth of 12% was fueled by a 10% increase in volumes across all business segments. The company also successfully navigated Middle East supply disruptions without losing production time.
- How did the new agro CDMO facility contribute to the results?
- The company began dispatching products from the new facility during the quarter. This is part of a broader strategy that management expects will drive sequential growth in the coming fiscal year.
- What is the total dividend payout for the year?
- The board recommended a final dividend of ₹2.50 per share. This brings the total dividend for FY26 to ₹5 per share.
- What is the outlook for the next financial year?
- Management anticipates sequential growth in both revenue and EBITDA starting in Q1FY27. They expect the specialty chemicals and nutrition segments to lead this expansion.
Story so far
All notes on JUBLINGREA →- 26 May 2026 · 3:00 PM IST Jubilant Ingrevia hits 14-quarter revenue high on 12% growth
- 1d ago Jubilant Ingrevia's Q4 call transcript is out. It adds nothing new.
- 4d ago Jubilant Ingrevia's $300M agro client faces financial distress
- 4d ago Jubilant Ingrevia hits 14-quarter profit high on volume recovery
- 4d ago Jubilant Ingrevia reports 5% revenue growth for FY26